7-Chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, 95.0%, 100g

(4-(1H-1,2,3-TRIAZOL-1-YL)PHENYL)METHANAMINE HCL, 95.0%, 500mg

E-Plan fase EPLPHi 10x/0,25 objetivo IOS corregido al infinito. Distancia de trabajo 5,95 mm

1,3-Dibromoadamantane (purified by sublimation)>99.0%(GC)1g

8-Bromo-2-chloro-5-methoxyquinoline-3-carbaldehyde, 98%, 5g

VALIDAMYCIN, 97%, 25g

(S)-4-Benzyl-2-oxazolidinone, 98.0%, 1kg

(2-Fluoro-5-(hydrazinecarbonyl)phenyl)boronic acid, 95%, 1g

Talco, Ph.Eur., USP, polvo, aproximadamente 44 µm, 250 g, envase de plástico.

trans-2,5-Diethylpiperazine, 98%, 100mg

Calcein (mixture of isomers), 95.0%, 10g

Tinte de Giemsa, 5 g.

(Diacetoxyiodo)benzene, 98.0%, 1kg